Emma Heming Willis is sharing new details about husband Bruce Willis' frontotemporal dementia diagnosis. During Wednesday's episode of the "Conversations with Cam" podcast, the 47-year-old opened up ...

As global energy demand surges—driven by AI-hungry data centers, advanced manufacturing, and electrified transportation—researchers at the National Renewable Energy Laboratory have unveiled a ...

I have a custom ATMEGA328PB board and have alread burned bootloader with arduino uno. I used an external 16MHz. When i tried to upload a simple blinking sketch to the board using FTDI module, i ...

A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative ...

Emma Heming Willis has had to adapt to life as not only a wife but as a caregiver of her husband, Bruce Willis, as he battles frontotemporal dementia (FTD). And one of those shifts is in the way they ...

Corinne Purtill is a science and medicine reporter for the Los Angeles Times. Her writing on science and human behavior has appeared in the New Yorker, the New York Times, Time Magazine, the BBC, ...

The primary method here is to visit the FTDI website and search & download the drivers you’re looking for. Here’s how that can be done: Open your web browser and visit the FTDI driver download center ...

How can apathy be managed in an individual with frontotemporal dementia? Frontotemporal dementia or frontotemporal degeneration (FTD) refers to a range of disorders that impact the brain’s frontal ...

If you’re using Blink home security cameras and you don’t already have a Blink Sync Module 2, the Blink Sync Module XR delivers a host of benefits. I’m a big fan of security cameras with the capacity ...

The global solar module industry is expected to regain a sustainable balance in the next six months, Yana Hryshko, head of Solar Supply Chain Research for Wood Mackenzie, told pv magazine. She ...

Coya Therapeutics, Inc. has Treg therapies for neurodegenerative and autoimmune diseases, targeting ALS, FTD, AD, and PD. However, their lead candidate is now clearly COYA 302. This drug basically ...